Upcoming exascale high performance computing (HPC) systems are expected to comprise multi-tier storage hierarchy, and thus will necessitate innovative storage and I/O mechanisms. Traditional disk and block-based interfaces and file systems face severe challenges in utilizing capabilities of storage hierarchies due to the lack of hierarchy support and semantic interfaces. Object-based and semantically-rich data abstractions for scientific data management on large scale systems offer a sustainable solution to these challenges. Such data abstractions can also simplify users involvement in data movement. In this paper, we take the first steps of realizing such an object abstraction and explore storage mechanisms for these objects to enhance I/O performance, especially for scientific applications. We explore how an object-based interface can facilitate next generation scalable computing systems by presenting the mapping of data I/O from two real world HPC scientific use cases: a plasma physics simulation code (VPIC) and a cosmology simulation code (HACC). Our storage model stores data objects in different physical organizations to support data movement across layers of memory/storage hierarchy. Our implementation sclaes well to 16K parallel processes, and compared to the state of the art, such as MPI-IO and HDF5, our object-based data abstractions and data placement strategy in multi-level storage hierarchy achieves up to 7× I/O performance improvement for scientific data.

Substance P (SP) is a sensory neuropeptide that is expressed by the neurons innervating bone. There is considerable evidence that SP can regulate bone cell function in vitro, but it is unclear whether SP modulates bone modeling or remodeling in vivo. To answer this question we characterized the bone phenotype of mice with deletion of the Tac1 gene expressing SP. The phenotypes of 2-month-old and 5-month-old SP deficient mice and their wildtype controls were characterized by using μCT imaging, static and dynamic bone histomorphometry, and urinary deoxypyridinoline cross-links (DPD) measurement. No differences in bone phenotypes were observed between the 2 strains at 2 months of age. By 5 months both the wildtype and SP deficient mice had developed cancellous osteopenia, but relative to the wild-type mice the SP deficient mice had significantly greater cancellous bone loss. The SP deficient mice also exhibited decreased bone formation, increased osteoclast number, and increased urinary DPD levels. Cortical defect early repair was delayed in 5-month-old mice lacking SP. Collectively, these findings indicate that SP signaling is not required for bone modeling, but SP signaling reduces age-related osteopenia and accelerates cortical defect reparation, data supporting the hypothesis that SP is an anabolic physiologic regulator of bone metabolism.